Laurence A. Turka, Chief Scientific Officer at Rubius Therapeutics, Inc. (RUBY), sold 2,593 shares at $0.24 ($622) on 2023-01-31, disclosed to the SEC on 2023-01-31.
Open-market sale of $622 RUBY by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.